These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4698566)

  • 1. Parkinsonism treated with 3-O-methyldopa.
    Calne DB; Reid JL; Vakil SD
    Clin Pharmacol Ther; 1973; 14(3):386-9. PubMed ID: 4698566
    [No Abstract]   [Full Text] [Related]  

  • 2. A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain.
    Fahn S; Prasad AL; Delesie R
    Anal Biochem; 1972 Apr; 46(2):557-75. PubMed ID: 4337048
    [No Abstract]   [Full Text] [Related]  

  • 3. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 4. A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients.
    Curzon G; Kantamaneni BD; Trigwell J
    Clin Chim Acta; 1972 Mar; 37():335-41. PubMed ID: 5022098
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
    Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 7. 3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease.
    Sharpless NS; Muenter MD; Tyce GM; Owen CA
    Clin Chim Acta; 1972 Mar; 37():359-69. PubMed ID: 5022100
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergism of levodopa by alpha methyldopa.
    Fermaglich J; O'Doherty DS
    Trans Am Neurol Assoc; 1971; 96():231-4. PubMed ID: 5159089
    [No Abstract]   [Full Text] [Related]  

  • 9. The metabolism of L-3-O-methyldopa, a precursor of dopa in man.
    Kuruma I; Bartholini G; Tissot R; Pletscher A
    Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1972 Jun; 47(6):389-95. PubMed ID: 5041685
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction between levodopa and methyldopa.
    Gibberd FB; Small E
    Br Med J; 1973 Apr; 2(5858):90-1. PubMed ID: 4573316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.
    Calne DB; Petrie A; Rao S; Reid JL; Vakil SD
    Br J Pharmacol; 1972 Jan; 44(1):162-4. PubMed ID: 5015036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa.
    Kofman OS
    Arch Neurol; 1973 Aug; 29(2):120-1. PubMed ID: 4717719
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa and pressor amine sensitivity in parkinsonism.
    Reid JL; Calne DB; George CF; Vakil SD
    Clin Pharmacol Ther; 1972; 13(3):400-6. PubMed ID: 5026378
    [No Abstract]   [Full Text] [Related]  

  • 15. Methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
    Sweet RD; Lee JE; McDowell FH
    Clin Pharmacol Ther; 1972; 13(1):23-7. PubMed ID: 5008190
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
    Sweet RD; Lee JE; McDowell F
    Trans Am Neurol Assoc; 1971; 96():59-65. PubMed ID: 5159130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methyldopa and levodopa].
    Chang CP
    Zhonghua Yi Xue Za Zhi; 1974; 7():439-41. PubMed ID: 4211508
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dopa metabolism in relation to the therapy of Parkinson's syndrome].
    Pletscher A; Bartholini G
    Actual Pharmacol (Paris); 1971; 24():27-49. PubMed ID: 5150621
    [No Abstract]   [Full Text] [Related]  

  • 19. Methyldopa or methyldopahydrazine as levodopa synergists.
    Fermaglich J; Chase TN
    Lancet; 1973 Jun; 1(7814):1261-2. PubMed ID: 4122619
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain tissue and plasma assay of L-DOPA and alpha-methyldopa metabolites by high performance liquid chromatography with electrochemical detection.
    Freed CR; Asmus PA
    J Neurochem; 1979 Jan; 32(1):163-8. PubMed ID: 759567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.